Adult systemic anaplastic large-cell lymphoma: recommendations for diagnosis and management

Anaplastic Large Cell Lymphomas

(2015) Xiaoming Xing et al.   ADVANCES IN ANATOMIC PATHOLOGY

Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma

(2015) Rebecca L Boddicker et al.   Biomarkers in Medicine

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma

(2015) Ramona Crescenzo et al.   CANCER CELL

Experience of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma and relapsed/refractory systemic anaplastic large-cell lymphoma in the Named Patient Program: Review of the literature

(2015) P.L. Zinzani et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK

(2015) Phillip B. Murray et al.   Science Signaling

FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase

(2015) Jikui Guan et al.   eLife

Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK

(2015) Phillip B. Murray et al.   Science Signaling

Diagnostic Accuracy of a Defined Immunophenotypic and Molecular Genetic Approach for Peripheral T/NK-cell Lymphomas

(2014) Eric D. Hsi et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

(2014) E. R. Parrilla Castellar et al.   BLOOD

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

(2014) J. Iqbal et al.   BLOOD

Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies

(2014) Nancy L Bartlett et al.   Journal of Hematology & Oncology

Survival in patients with limited-stage peripheral T-cell lymphomas

(2014) Robert Briski et al.   LEUKEMIA & LYMPHOMA

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

(2014) Benjamin J. Solomon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphoma

(2013) C. Damm-Welk et al.   BLOOD

NovelTRAF1-ALKfusion identified by deep RNA sequencing of anaplastic large cell lymphoma

(2013) Andrew L. Feldman et al.   GENES CHROMOSOMES & CANCER

Peripheral T-cell and NK-cell lymphomas and their mimics; taking a step forward - report on the lymphoma workshop of the XVIth meeting of the European Association for Haematopathology and the Society for Hematopathology

(2013) Ayoma D Attygalle et al.   HISTOPATHOLOGY

Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma

(2013) Sonali M. Smith et al.   JOURNAL OF CLINICAL ONCOLOGY

Survival of Patients With Peripheral T-Cell Lymphoma After First Relapse or Progression: Spectrum of Disease and Rare Long-Term Survivors

(2013) Vivien Mak et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular Profiling Improves Classification and Prognostication of Nodal Peripheral T-Cell Lymphomas: Results of a Phase III Diagnostic Accuracy Study

(2013) Pier Paolo Piccaluga et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast Implant–Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients

(2013) Roberto N. Miranda et al.   JOURNAL OF CLINICAL ONCOLOGY

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

(2013) Yael P Mossé et al.   LANCET ONCOLOGY

STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemia

(2013) R S Ohgami et al.   LEUKEMIA

t(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 via STAT5

(2013) Stefan Ehrentraut et al.   PLoS One

The spectrum of primary mucosal CD30-positive T-cell lymphoproliferative disorders of the head and neck

(2013) WeiGe Wang et al.   Oral Surgery Oral Medicine Oral Pathology Oral Radiology

Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas

(2012) G. Vasmatzis et al.   BLOOD

Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphoma

(2012) L. Agnelli et al.   BLOOD

Anaplastic large cell lymphoma, ALK-negative

(2012) Andrés J.M. Ferreri et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study

(2012) I. Oschlies et al.   HAEMATOLOGICA

Long-Term Outcome of Adults With Systemic Anaplastic Large-Cell Lymphoma Treated Within the Groupe d'Étude des Lymphomes de l'Adulte Trials

(2012) David Sibon et al.   JOURNAL OF CLINICAL ONCOLOGY

Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study

(2012) Barbara Pro et al.   JOURNAL OF CLINICAL ONCOLOGY

Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01

(2012) Francesco d'Amore et al.   JOURNAL OF CLINICAL ONCOLOGY

EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma

(2011) W. Kempf et al.   BLOOD

Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing

(2010) A. L. Feldman et al.   BLOOD

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

(2010) N. Schmitz et al.   BLOOD

Gene Expression Profiling Uncovers Molecular Classifiers for the Recognition of Anaplastic Large-Cell Lymphoma Within Peripheral T-Cell Neoplasms

(2010) Roberto Piva et al.   JOURNAL OF CLINICAL ONCOLOGY

PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus

(2010) Andrew L Feldman et al.   MODERN PATHOLOGY

Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies

(2010) David A Wada et al.   MODERN PATHOLOGY

Distribution ofNPM1-ALKandX-ALKfusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation

(2009) Christine Damm-Welk et al.   BRITISH JOURNAL OF HAEMATOLOGY

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

(2008) K. J. Savage et al.   BLOOD

Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas

(2008) Itziar Salaverria et al.   BRITISH JOURNAL OF HAEMATOLOGY

Graft-Versus-Lymphoma Effect for Aggressive T-Cell Lymphomas in Adults: A Study by the Société Française de Greffe de Moëlle et de Thérapie Cellulaire

(2008) Steven Le Gouill et al.   JOURNAL OF CLINICAL ONCOLOGY

International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes

(2008)   JOURNAL OF CLINICAL ONCOLOGY

Autologous Stem-Cell Transplantation As First-Line Therapy in Peripheral T-Cell Lymphomas: Results of a Prospective Multicenter Study

(2008) Peter Reimer et al.   JOURNAL OF CLINICAL ONCOLOGY

Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas

(2008) A L Feldman et al.   LEUKEMIA

Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder

(2008) Anja C Roden et al.   MODERN PATHOLOGY